Notice Regarding the Conclusion of an Exclusive Distribution Agreement in Japan for the "iHEAL" Brand

Our group (hereinafter referred to as "Jelly Beans", President and CEO: Akira Miyazaki) resolved at the Board of Directors meeting held today to conclude an exclusive distribution agreement (hereinafter referred to as the "Agreement") in Japan with AIDEN LAB JAPAN Co., Ltd. (hereinafter referred to as "AIDEN") and BIOLAB Corp. (hereinafter referred to as "BIOLAB"), and we hereby announce that the Agreement was concluded on the same date.

1. Purpose of the Agreement

This Agreement is a three-party contract where BIOLAB will be responsible for the manufacturing and supply of "iHEAL" brand products, and AIDEN will handle import agency. Jelly Beans will acquire the rights for exclusive sales and marketing of "iHEAL" brand products in Japan, becoming the general distributor in Japan.

Jelly Beans possesses experienced personnel and industry recognition and networks in its core business of women's shoes. Through this Agreement, we will be able to directly manage, wholesale, and sell products online in Japan. We will leverage the synergy effects with popular brands in South Korea to develop the Japanese market.

Full-scale sales are scheduled to begin in the second half of the fiscal year ending January 2027, and we will accelerate growth towards expanding sales in Japan.

2. Regarding the "iHEAL" Brand

This is a women's inner care and femcare brand originating from South Korea, developed by BIOLAB, which is known for its patented femcare lactic acid bacteria. Their main product is "Vaginal Lactobacilli (Female Probiotics)". Many purchasers buy it for purposes such as managing odor in the delicate zone, vaginal flora, physical condition during fertility treatment, and post-antibiotic care. It is handled as a popular product at Olive Young, a well-known retailer in South Korea.

Furthermore, it has won the Qoo10 Award*1 for two consecutive years in 2024 and 2025. Its popularity is also growing in Japan, and we will expand sales in the Japanese market.

(*1: An award where sellers are recognized based on excellent sales performance and customer satisfaction on the e-commerce mall Qoo10.)

[Femcare Market]

The femcare market is expanding in scale year by year. The global femtech market is projected to be approximately $9.1 billion (approx. 1.4 trillion yen) in 2025 and approximately $41.1 billion (approx. 6.5 trillion yen)*1 by 2034. In Japan, it is a noteworthy market estimated at approximately 80.4 billion yen*2 in 2024. Jelly Beans has handled women's shoes for 50 years and has a track record of sales activities targeting women. Based on this experience, we will approach the femcare market in a way that only we can, and work towards expanding our market share.

(Sources *1: FORTUNE BUSINESS INSIGHTS Research Report 2025, *2: Yano Research Institute Market Research Report 2025)

About Jelly Beans Group

Jelly Beans Group Co., Ltd. is a holding company that oversees multiple operating companies, engaged in businesses across a wide range of fields including fashion, sports, sustainability, logistics, and entertainment. In addition to planning and developing original brands, wholesale, retail, and e-commerce operations, we actively engage in supporting the development of global brands and creating new businesses. Our strength lies in our ability to provide integrated services from brand strategy planning, marketing, promotion, to supply chain construction by fusing the expertise and know-how of each group company. We continue to grow as a comprehensive marketing company that consistently creates new value by accurately grasping market and era changes.

Contact Information for Inquiries Regarding This Matter

Jelly Beans Group Co., Ltd.

https://www.jelly-beans-group.co.jp/

IR & Public Relations

https://www.jelly-beans-group.co.jp/contact/